Press releases
September 13, 2023
UMCG and Inflammatix Collaborate to Improve Early Recognition and Clinical Decision Support for Sepsis Care
July 10, 2023
Inflammatix Appoints Heiner Dreismann as New Board Member
June 15, 2022
Inflammatix Appoints Dr. Purvesh Khatri as Chief Scientific Officer
November 30, 2021
Inflammatix Appoints Dr. Kian Beyzavi as New Board Member
November 18, 2021
Inflammatix Announces Additional $12.1 Million Funding from BARDA for ViraBac EZ Acute Infection Test
November 11, 2021
Inflammatix Awarded $1.7 Million Grant From National Institutes of Health (NIH)
March 16, 2021
Inflammatix Secures $102 Million in Series D Financing Led by D1 Capital Partners to Commercialize Novel Host Response Diagnostics
October 29, 2020
Inflammatix Announces $7.4 Million in Additional BARDA Funding to Advance ViraBac EZ Acute Infection Test